Friday, March 1, 2024 |

Medifast invests $20M to expand into weight-loss drug market

December 14, 2023

Medifast Inc. has invested $20 million in a virtual health care provider as the Harbor East company makes a push into the booming weight loss drug market amid a slowdown in revenue. The partnership will blend Medifast’s coaching and diet-based approach with LifeMD doctors who can prescribe weight loss drugs like Ozempic to Medifast customers. Medifast (NYSE: MED) is purchasing $10 million of LifeMD (Nasdaq: LMFD) stock and contributing $10 million to LifeMD to launch the collaboration and improve the telehealth platform. Medifast CEO Dan Chard will join the board of directors at New York-based LifeMD as part of the deal.

Article Source: Baltimore Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.